NioCorp Developments Ltd. (”NioCorp” or the “Company”) (NASDAQ:NB) today announced the pricing of its previously announced ...

The Securities and Exchange Commission has declared that Crypto Bridge Exchange, also known as CBEX, is not registered to ...

Cue Biopharma (NASDAQ:CUE) announced the pricing details of its underwritten public offering. The offering includes (i) 13,530,780 shares of its common stock, along with warrants to purchase an ...

Sitka Gold Corp. (TSXV: SIG) ("Sitka" or the "Company") is pleased to announce it has closed its previously announced "bought ...

The healthcare tech firm wants to raise capital to fund its operations and buy more Bitcoin, though a definitive amount was ...

The chairman of the Securities and Exchange Board of India said on Thursday that the market regulator was working to sort out ...

The offering is expected to close on or about April 16, 2025. All the securities are being offered by Cue Biopharma. Shares were down 6.5% in premarket trade on Tuesday.

Opinion: Eversheds Sutherland attorneys Michael Bahar, Mary Jane Wilson-Bilik, and Alexander Fuchs warn companies that ...

Oppenheimer & Co. Inc. is acting as sole book-running manager for the offering. Newbridge Securities Corporation is acting as co-manager for the offering.

SEBI chief Tuhin Kanta Pandey says efforts are underway to resolve issues delaying NSE's IPO, emphasizing public interest ...

AGNCM and AGNCO preferred stocks outperformed the S&P500 with 40.7% & 33.4% returns. Read here for an analysis of these ...